Literature DB >> 1572696

Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.

M Vajdy1, N Y Lycke.   

Abstract

This study was conducted to investigate whether cholera toxin (CT), used as a mucosal adjuvant, would promote the development in mice of immunological memory to unrelated antigens administered by the oral route. We found that oral priming immunizations with keyhole limpet haemocyanin (KLH) in combination with CT adjuvant induced long-term, at least 22 months and perhaps lifelong, immunological memory in the intestinal lamina propria (LP). In contrast, oral priming immunizations with KLH alone failed to stimulate immunological memory. Moreover, memory responses in the KLH plus CT-immunized mice were elicited by antigen alone, i.e. without CT adjuvant, suggesting that once immunological memory is established in the intestinal mucosa, e.g. by oral vaccination, elicitation of secondary-type responses does not require the presence of CT and thus could result from re-encounter with specific bacterial or viral antigens in the intestine. We also found that a single priming-dose of KLH plus CT adjuvant was sufficient to stimulate long-term, antigen-specific memory in the intestinal mucosa. Finally, the ability of CT to induce immunological memory in the gut mucosa required the whole toxin and could not be achieved by using the toxoid, the cholera toxin B subunit (CTB), which lacks the adenylate cyclase/cAMP-activating property of the whole molecule. The results support the view that mucosal adjuvants, incorporated into oral vaccines, might be an effective means to achieve long-term immunological memory and protection against pathogenic micro-organisms at mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572696      PMCID: PMC1384744     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Combined oral/nasal immunization protects mice from Sendai virus infection.

Authors:  J G Nedrud; X P Liang; N Hague; M E Lamm
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

2.  Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro.

Authors:  A Bromander; J Holmgren; N Lycke
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

3.  Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.

Authors:  N Lycke; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

4.  Five-year immunologic memory in Swedish volunteers after oral cholera vaccination.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

5.  B-cell memory is short-lived in the absence of antigen.

Authors:  D Gray; H Skarvall
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

6.  Memory B cells express a phenotype consistent with migratory competence after secondary but not short-term primary immunization.

Authors:  G Kraal; I L Weissman; E C Butcher
Journal:  Cell Immunol       Date:  1988-08       Impact factor: 4.868

7.  Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

8.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

9.  The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens.

Authors:  N Lycke; U Karlsson; A Sjölander; K E Magnusson
Journal:  Scand J Immunol       Date:  1991-06       Impact factor: 3.487

10.  H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.

Authors:  Y Hirabayashi; S I Tamura; Y Suzuki; T Nagamine; C Aizawa; K Shimada; T Kurata
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

View more
  38 in total

1.  Pollen grains for oral vaccination.

Authors:  Shashwati U Atwe; Yunzhe Ma; Harvinder Singh Gill
Journal:  J Control Release       Date:  2014-08-23       Impact factor: 9.776

2.  Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.

Authors:  Aletta C Schnitzler; Jennifer M Burke; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

Review 3.  Impact of aging on gastrointestinal mucosal immunity.

Authors:  D L Schmucker; M F Heyworth; R L Owen; C K Daniels
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 4.  Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?

Authors:  W C Koff; A M Schultz
Journal:  J Clin Immunol       Date:  1996-05       Impact factor: 8.317

5.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

6.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Immunoglobulin response to intrapulmonary immunization of asthmatics.

Authors:  M Schuyler; C R Lyons; B Masten; D Bice
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

8.  Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice.

Authors:  A Lemke; M Kraft; K Roth; R Riedel; D Lammerding; A E Hauser
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

9.  Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.

Authors:  T G Blanchard; N Lycke; S J Czinn; J G Nedrud
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

10.  Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.

Authors:  D W McGee; C O Elson; J R McGhee
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.